Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 1486 AL 1500

[Caring for young patients with Alzheimer's disease or associated disorders in day care centers of the Rhône-Alpes region]

Pongan É, Padovan C, Coste MH, Krolak-Salmon P, Rouch I.

Geriatr Psychol Neuropsychiatr Vieil. 2012 Sep;10(3):343-8. doi: 10.1684/pnv.2012.0354.

What are the prospects of slowing the progression of Alzheimer's disease?

Palmer AM.

Drug Discov Today. 2012 Nov;17(21-22):1157-9. doi: 10.1016/j.drudis.2012.09.009. Epub 2012 Oct 2.

On the issue of transmissibility of Alzheimer disease: a critical review

Schmidt C, Karch A, Korth C, Zerr I.

Prion. 2012 Nov-Dec;6(5):447-52. doi: 10.4161/pri.22502. Epub 2012 Oct 10.

Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies

Schneider JA, Arvanitakis Z, Yu L, Boyle PA, Leurgans SE, Bennett DA.

Brain. 2012 Oct;135(Pt 10):3005-14. doi: 10.1093/brain/aws234.

Effect of selective serotonin reuptake inhibitors in Alzheimer's disease with comorbid depression: a meta-analysis of depression and cognitive outcomes

Sepehry AA, Lee PE, Hsiung GY, Beattie BL, Jacova C.

Drugs Aging. 2012 Oct;29(10):793-806. doi: 10.1007/s40266-012-0012-5.

Estrogens and Alzheimer disease risk: is there a window of opportunity?

Henderson VW, Rocca WA.

Neurology. 2012 Oct 30;79(18):1840-1. doi: 10.1212/WNL.0b013e318271f88f. Epub 2012 Oct 24.

Effectiveness of antidementia drugs in delaying Alzheimer's disease progression

Rountree SD, Atri A, Lopez OL, Doody RS.

Alzheimers Dement. 2013 May;9(3):338-45. doi: 10.1016/j.jalz.2012.01.002. Epub 2012 Oct 24.

Age of major depression onset, depressive symptoms, and risk for subsequent dementia: results of the German study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe)

Heser K, Tebarth F, Wiese B, Eisele M, Bickel H, Köhler M, Mösch E, Weyerer S, Werle J, König HH, Leicht H, Pentzek M, Fuchs A, Riedel-Heller SG, Luppa M, Prokein J, Scherer M, Maier W, Wagner M; Age CoDe Study Group.

Psychol Med. 2013 Aug;43(8):1597-610. doi: 10.1017/S0033291712002449. Epub 2012 Nov 9.

Splice variants of the Alzheimer's disease beta-secretase, BACE1

Holsinger RM, Goense N, Bohorquez J, Strappe P.

Neurogenetics. 2013 Feb;14(1):1-9. doi: 10.1007/s10048-012-0348-3. Epub 2012 Nov 11.

Health disparities in cost of care in patients with Alzheimer's disease: an analysis across 4 state Medicaid populations

Gilligan AM, Malone DC, Warholak TL, Armstrong EP.

Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):84-92. doi: 10.1177/1533317512467679. Epub 2012 Nov 29.

Prevalence of neuropsychiatric symptoms in young-onset compared to late-onset Alzheimer's disease - part 1: findings of the two-year longitudinal NeedYD-study

van Vliet D, de Vugt ME, Aalten P, Bakker C, Pijnenburg YA, Vernooij-Dassen MJ, Koopmans RT, Verhey FR.

Dement Geriatr Cogn Disord. 2012;34(5-6):319-27. doi: 10.1159/000342824. Epub 2012 Dec 3.

Gender differences in lay persons' beliefs and knowledge about Alzheimer's disease (AD): a national representative study of Israeli adults

Werner P, Goldberg S, Mandel S, Korczyn AD.

Arch Gerontol Geriatr. 2013 Mar-Apr;56(2):400-4. doi: 10.1016/j.archger.2012.11.001. Epub 2012 Dec 6.

Vitamin B12 intake and status and cognitive function in elderly people

Doets EL, van Wijngaarden JP, Szczecińska A, Dullemeijer C, Souverein OW, Dhonukshe-Rutten RA, Cavelaars AE, van 't Veer P, Brzozowska A, de Groot LC.

Epidemiol Rev. 2013;35:2-21. doi: 10.1093/epirev/mxs003. Epub 2012 Dec 5.

Alzheimer's disease and mortality in traditional long-term care facilities

Cereda E, Pedrolli C, Zagami A, Vanotti A, Piffer S, Faliva M, Rondanelli M, Caccialanza R.

Arch Gerontol Geriatr. 2013 May-Jun;56(3):437-41. doi: 10.1016/j.archger.2012.12.001. Epub 2012 Dec 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias